Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Thoracolumbar fascia mobilization versus ultrasound-guided 5% dextrose injection for chronic low back pain

Official title: Comparison of the Effectiveness of Thoracolumbar Fascia Mobilization and Ultrasound-Guided Thoracolumbar Interfascial 5% Dextrose Injection in Patients With Chronic Low Back Pain

Run by Ankara City Hospital Bilkent · NCT07241559 · Data updated 2026-11-12

This study will try two treatments—hands-on thoracolumbar fascia mobilization and ultrasound-guided 5% dextrose injections—to see if they reduce pain and improve movement and function in adults with chronic low back pain who have not adequately improved with medical treatment.

More Chronic Low-back Pain trials

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment75 (estimated)
SponsorAnkara City Hospital Bilkent
Academic / other
Locations1 site (Ankara, Altındağ)
StatusRecruiting
StartedNovember 1, 2025
Main results expectedApril 1, 2026
Study endsJuly 1, 2026
Registry record updatedMay 7, 2026
Trial IDNCT07241559 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–65 with nonspecific low back pain lasting more than three months who have not had an adequate response to medical treatment and who meet the trial's exclusion criteria are ideal candidates.

Probably not a fit

Patients with prior spinal surgery, radiculopathy or disc pathology causing nerve root symptoms, spinal stenosis/spondylolysis/spondylolisthesis, BMI over 30, pregnancy, coagulation disorders, recent physical therapy or lumbar injections, local infection, or active inflammatory or malignant disease are unlikely to be eligible or to benefit from these interventions in this trial.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized interventional trial compares hands-on thoracolumbar fascia mobilization with ultrasound-guided interfascial injections of 5% dextrose in adults who have nonspecific chronic low back pain. Participants are assigned to one of three groups, with the mobilization group receiving standardized myofascial release twice weekly for three weeks and the injection group treated under ultrasound guidance to the thoracolumbar interfascial space. Primary outcomes include pain intensity, lumbar range of motion, and functional disability, while secondary outcomes include quality of life, proprioception, and thoracolumbar fascia thickness and echogenicity. Eligible participants are adults aged 18–65 without prior spinal surgery, radiculopathy, major inflammatory or malignant disease, recent manual therapy or injections, or other exclusionary conditions.

Why it matters

Potential benefit: If successful, these approaches could reduce chronic low back pain and improve mobility, daily function, and quality of life for affected patients.

How similar studies have gone: Smaller randomized and observational studies of dextrose prolotherapy and of myofascial release have shown mixed but sometimes promising results for chronic low back pain, and direct head-to-head comparisons remain relatively limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Male or female patients aged 18 to 65 years
2. Presence of low back pain lasting longer than 3 months
3. No adequate response to medical treatment
4. Voluntary participation in the study

Exclusion Criteria:

1. Age below 18 or above 65 years
2. Body mass index (BMI) greater than 30 kg/m²
3. Pregnancy or breastfeeding
4. Presence of coagulation disorders
5. History of spinal surgery
6. Presence of inflammatory or malignant diseases
7. Local infection at the spine or injection site
8. Presence of lumbar disc pathology causing radiculopathy
9. Presence of spinal stenosis, spondylolysis, or spondylolisthesis
10. Participation in physical therapy or any manual therapy within the past 6 months
11. Receiving lumbar injections within the past 6 months
12. History of allergy to injection materials
13. Refusal to participate in the study

Where it's running

  • Ankara Training and Research Hospital
    Ankara, Altındağ, Turkey (Türkiye)
    Recruiting

Study contacts

  • Principal investigator: Büşra ALÇIN, Medical Doctor — Ankara Training and Research Hospital
  • Study coordinator: Barış NACIR, Professor Doctor
  • Email: drbarisnacir@gmail.com
  • Phone: +905327278724

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.